GHK-Cu is the copper(II) complex of glycyl-L-histidyl-L-lysine (Gly-His-Lys), a tripeptide first isolated from human serum albumin in 1973 whose concentration declines with age
Detailed administration protocols, IV vs IM dosing guidance, storage requirements, subject screening criteria, contraindications, drug-interaction guidance, and session-spacing recommendations are delivered exclusively to verified practitioners via the Blaque Sigma protocol library with your order confirmation
Although this area of study is still emerging, it highlights potential new directions for understanding NNMTs role in adipose biology
The honest answer is that the human safety data is limited compared to decades-old pharmaceuticals, but the preclinical safety record across multiple species is unusually clean for a peptide with this level of biological activity
below 150 pg/mL is clinical deficiency)